At a Glance
- Study Type: Survey
- Condition: Premutation or full mutation Fragile X
- Age: 0–13
- Sex: All
- Participant: Parent
- Location: Home
- Travel Considerations: No travel required
- Sponsor: The John Merck Fund
Parents of children ages 0-13 with full or premutation Fragile X needed for a survey
RTI International is conducting a survey to learn about the early needs and experiences of families with children, aged 13 or younger, who have been diagnosed with either the full or the premutation of Fragile X.
The online survey should take about 20–90 minutes to complete, depending on the number of eligible children (see more below). The survey may be completed in more than one sitting.
Parents of children with premutation or full mutation Fragile X that meet one of these age requirements may be eligible to participate:
- Age 0–7 (under 8)
- Age 0–13 (under 14) and is the first child diagnosed in family
What to Expect
The survey is online and parents will answer a set of questions for each child:
- First child diagnosed (age 0–13) — approx. 10 min.
- Children (age 0–7) — approx. 45 min. each
The survey can be completed all at the same time, or divided into more than one sitting.
A Mom Shares Her and Her Son’s Experience Participating in a Fragile X Clinical Trial »
Diane and her son Joshua volunteered for a clinical trial a little over a year ago. In this heartwarming video, his mom shares how their family made the decision to participate, and what the experience has been like so far.
Dr. Elizabeth Berry-Kravis on the Challenges Inherent in a Clinical Trial »
We asked NFXF scientific advisor, doctor, and clinical researcher Dr. Elizabeth Berry-Kravis to comment on the challenges inherent in a clinical trial.
Clinical Trials From Start to Finish (Webinar) »
Sharyn Lincoln and Katherine Pawlowski of Boston Children’s Hospital speaks with us about how clinical research trials work, what it takes to participate, and what happens after the study.
Learn About Clinical Trials »
From ClinicalTrials.gov, maintained by the National Library of Medicine (NLM) at the National Institutes of Health (NIH).
Need More Information?
Our Most Recent Opportunities
Individuals with FXS who are 18 years or older and able to talk fluently about own experiences, and their caregivers and providers may be eligible to participate. Eligible providers include teachers, psychologists, social workers, and physicians.
NFXF has partnered with an advisory committee of international fragile X professionals to create an international fragile X premutation research registry. Find out how to participate.
A Mount Sinai Genetic Counseling graduate student is conducting a research study to learn about possible benefits and side effects of CBD supplements when used to treat FXS symptoms. This information will be obtained by using an anonymous online parental and caregiver survey. About the Survey Who can participate? Parents and caregivers caring for somebody with FXS who uses, or has used, CBD supplements may be eligible to participate. The parent or caregiver responding to the survey must be at least 18 years old. The individual with ...
Participants of this study will explore what information is considered most important to recently diagnosed fragile X premutation carriers. Open to premutation carriers 18 and over who were diagnosed sometime since January 2018.
Kaylynn Shuleski, a master’s in genetic counseling candidate, is conducting a research study to explore the concerns and challenges caregivers may face when planning long-term supports and living arrangements for their adult children with Fragile X syndrome (FXS). This information will be valuable for current and future families when considering long-term supports, as well as for healthcare professionals, counselors, and policy makers. About the Study Who can participate? Parents and caregivers of adults with full mutation ...
Males between the ages of 18 and 30 years with a diagnosis of Fragile X syndrome (full mutation) may be eligible to participate.